Table 1.
Genotype 4 |
Genotype 5 |
Genotype 6 |
||||
Country | Prevalence | Country | Prevalence | Country | Prevalence | |
Africa | Egypt[10] | 91% | South Africa[22,23] | 40% | ||
Gabon[12] | 71% | |||||
Cameroon[7] | 76% | |||||
Nigeria[8] | 60% | |||||
Middle East | Saudi Arabia[11] | 60% | Syria[25] | 10% | ||
Lebanon[9] | 30% | Saudi Arabia[11] | 1% | |||
Syria[5] | 30% | |||||
Iraq[6] | 35.40% | |||||
Asia | China[33] | 0-1.7% | Hong Kong[33-35] | 10%-30% | ||
Vietnam[30] | 14% | |||||
South Korea[31] | 1.40% | |||||
China[32,35] | 0-50% | |||||
Europe | France[15] | 4%-10% | France[15,26] | 3%-14.2% | ||
Spain[17,20] | 1.4%-14% | Belgium[28] | 1%-5% | |||
Italy[16,19] | 1.4%-3.1% | Spain[27] | 0-10.3% | |||
Greece[18] | 13.2%-15.2% | Italy[24] | 0-0.1% | |||
Greece[18,29] | 0.4%-1.9% | |||||
America | United States[13,14] | 0-2% |